Human Holdings Co (2415) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
20 Jul, 2026Executive summary
Consolidated revenue for Q1 FY2025 increased by 3.4% year-over-year to ¥24,646 million, with all profit lines showing growth.
Operating income rose 15.2% year-over-year to ¥541 million, and ordinary income increased 18.0% to ¥568 million.
Net income attributable to parent company shareholders increased 14.1% year-over-year to ¥258 million.
Earnings per share for the quarter were ¥24.94, up from ¥20.86 in the same period last year.
Financial highlights
Revenue: ¥24,646 million (+3.4% YoY); Operating income: ¥541 million (+15.2% YoY); Ordinary income: ¥568 million (+18.0% YoY); Net income: ¥258 million (+14.1% YoY).
Gross profit for the quarter was ¥6,234 million, up from ¥5,986 million year-over-year.
Human Resources segment revenue grew 5.2% YoY, Education segment was flat (-0.2% YoY), Care segment up 3.8% YoY, Other segment up 4.5% YoY.
Operating margin improved to 2.2% from 2.0% YoY.
Comprehensive income for the quarter was ¥262 million, compared to ¥230 million in the prior year.
Outlook and guidance
Full-year net sales forecast for the year ending March 31, 2025, is ¥99,300 million, a 3.6% increase year-over-year.
Operating profit is projected at ¥3,300 million (up 4.8%), ordinary profit at ¥3,350 million, and profit attributable to owners of parent at ¥2,200 million (up 2.0%).
Dividend per share for FY2024 was increased to ¥62.50, up from ¥27.00, with a payout ratio policy raised to 30%.
Annual dividend per share forecast is ¥64.00.
Company expects to maintain listing standards with a free float ratio above 25%.
Latest events from Human Holdings Co
- Revenue and profit rose year-over-year, with strong human resources growth and stable outlook.2415
Q2 202520 Jul 2026 - Record revenue and profit growth, improved margins, and higher dividends with steady outlook.2415
Q4 202520 Jul 2026 - Profits and sales rose, record outlook set, and shareholder returns were enhanced.2415
Q3 202520 Jul 2026 - Revenue and profits grew strongly, with record full-year results and extraordinary gains expected.2415
Q2 202620 Jul 2026 - Revenue and profit increased across all segments, led by human resources and nursing care.2415
Q1 202620 Jul 2026 - Revenue up 1.9% YoY, but profits dipped; outlook and dividend forecast remain strong.2415
Q3 202620 Jul 2026 - Revenue and operating profit rose, but net profit fell 15% on extraordinary losses.2415
Q4 202620 Jul 2026